89bioETNB

那斯達克 · USD
9.16
-0.34
(-3.58%)
收盤 08/02 03:59 (UTC+8)
盤後 
(0%)
08/02 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
2022/Q4
營業收入淨額
-
-
-
-
-
-
-
-
-
-
營業成本
----------
營業毛利
-
-
-
-
-
-
-
-
-
-
營業費用
-----41,20639,34542,12928,52425,362
研發費用
64,394111,303141,44144,86547,42833,59231,41734,91522,30619,064
推銷及管理費用
11,51510,70210,4978,5719,8497,6147,9287,2146,2186,298
非經常性項目費用
----------
其他營業費用
----------
營業利益
-75,909
-122,005
-151,938
-53,436
-57,277
-41,206
-39,345
-42,129
-28,524
-25,362
其他收入及費用
6,0385,0995,4316,4736,5565,7045,5794,6301,7631,321
利息費用
1,2671,1912,3628748638669598942,075545
稅前純益
-71,138
-118,097
-148,869
-47,837
-51,584
-36,368
-34,725
-38,393
-28,836
-24,586
所得稅
137257204134973,867---16
稅後純益
-71,275
-118,354
-149,073
-47,971
-51,681
-40,235
-34,725
-38,393
-28,836
-24,602
基本每股稅後盈餘(元)
-0.49-1.02-1.39-0.48-0.54-0.50-0.45-0.52-0.54-0.48
稀釋每股稅後盈餘(元)
-0.49-1.05-1.44-0.48-0.54-0.50-0.44-0.52-0.54-0.30
基本平均股數(千股)
146365.00115955.00107075.0099831.0095846.0080696.0076336.0074126.0053171.0050809.00
稀釋平均股數(千股)
146365.00115955.00107075.0099831.0095846.0080696.0076336.0074126.0053171.0050809.00
還原基本每股稅後盈餘(元)
-0.49-1.02-1.39-0.48-0.54-0.50-0.45-0.52-0.54-0.48
還原稀釋每股稅後盈餘(元)
-0.49-1.05-1.44-0.48-0.54-0.50-0.44-0.52-0.54-0.30
還原基本平均股數(千股)
146,365115,955107,07599,83195,84680,69676,33674,12653,17150,809
還原稀釋平均股數(千股)
146,365115,955107,07599,83195,84680,69676,33674,12653,17150,809
EBITDA(千元)
-71,304-118,656-148,805-49,367-53,372-37,252-35,626-38,400-27,568-24,651

大家都在看

HOT